Rohann M. Correa

London, ON N6A5W9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Kidney Injury Molecule-1 (KIM-1) in Renal Cell Carcinoma: Biological Foundations and Emerging Clinical Applications.

Kidney Injury Molecule-1 (KIM-1) in Renal Cell Carcinoma: Biological Foundations and Emerging Clinical Applications.

Journal: Current oncology (Toronto, Ont.)

Published: April 27, 2026

Stepping through the PORTAL: moving toward personalised management of oligorecurrent prostate cancer.

Stepping through the PORTAL: moving toward personalised management of oligorecurrent prostate cancer.

Journal: The Lancet. Oncology

Published: December 18, 2025

Renal SABR: Implementation of A New Standard of Care.

Renal SABR: Implementation of A New Standard of Care.

Journal: International journal of radiation oncology, biology, physics

Published: September 26, 2025

Practical Aspects of Delivering Radiation for Polymetastatic Disease.

Practical Aspects of Delivering Radiation for Polymetastatic Disease.

Journal: International journal of radiation oncology, biology, physics

Published: September 26, 2025

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 02, 2025

The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trial.

The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trial.

Journal: Trials

Published: July 10, 2025

International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiation Therapy.

International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: June 03, 2025

Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney.

Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney.

Journal: International journal of radiation oncology, biology, physics

Published: May 12, 2025

Whack-a-met: serial SABR for repeated oligoprogression in metastatic CRPC.

Whack-a-met: serial SABR for repeated oligoprogression in metastatic CRPC.

Journal: Prostate cancer and prostatic diseases

Published: February 22, 2025

Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial.

Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial.

Journal: Brachytherapy

Published: February 06, 2025

Ablative Yttrium-90 Radioembolization Therapy for Nonmetastatic Renal Cell Carcinoma (ARRCC) Phase II Trial.

Ablative Yttrium-90 Radioembolization Therapy for Nonmetastatic Renal Cell Carcinoma (ARRCC) Phase II Trial.

Journal: Journal of vascular and interventional radiology : JVIR

Published: December 27, 2024

Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN): Results of a randomized clinical trial.

Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN): Results of a randomized clinical trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 18, 2024

Showing 1-12 of 60

Last Updated: 09/26/2026